Considerations for the use of biomaterials to support cell therapy in neurodegenerative disease

Victoria H Roberton1, James B Phillips1

  • 1UCL School of Pharmacy, University College London, London, United Kingdom; UCL Centre for Nerve Engineering, London, United Kingdom.